Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A close insight to factor VIII inhibitor in the congenital hemophilia A.

Expert review of hematology - 1 Sept 2016

Tabriznia-Tabrizi Shamsoreza, Gholampour Marzie, Mansouritorghabeh Hassan

Abstract excerpt

INTRODUCTION: Hemophilia A (HA) has an X-linked pattern of inheritance and is the most common of the hemorrhagic disorders. HA is caused by a decreased or deficiency of the functional clotting factor VIII (FVIII) and effects 1 in 5000-10,000 male births. The common treatment for hemophilia is replacement therapy by plasma-derived or recombinant FVIII. Approximately 20-30% of people with a severe type of HA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Lymphocytes
Share to Cell Communication
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemophilia A

Share to Isoantibodies

Share to Recombinant Proteins

Share to Severity of Illness Index

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 27367203
DOI: 10.1080/17474086.2016.1208554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A close insight to factor VIII inhibitor in the congenital hemophilia A.PMID 27367203Read ↗

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read ↗

[Research Progress on Genetic Factors and Hemophilia A Clotting Factor Inhibitor-Review].Semantic proximity Read ↗

Hemophilia A and B: molecular and clinical similarities and differencesSemantic proximity Read ↗

[The molecular bases of hemophilia A. ].Semantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

Regulation and importance of factor VIII levels in hemophilia A carriers.Semantic proximity Read ↗

Haemophilia.Semantic proximity Read ↗

Acquired hemophilia A: Updated review of evidence and treatment guidance.Semantic proximity Read ↗

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and ChallengesSemantic proximity Read ↗

Hemophilia: in review.Semantic proximity Read ↗

Diagnosis and management of hemophilia A and B.Semantic proximity Read ↗

Treatment related factors and inhibitor development in children with severe haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.